Gastrointestinal Cancer News

Simulation modeling revealed that the lower estimates of the rate of progression from Barrett’s esophagus to esophageal adenocarcinoma from population-based studies are likely more accurate than higher estimates from prospective studies due to detection bias from endoscopic surveillance.

Patients with Barrett’s esophagus and confirmed low-grade dysplasia who underwent radiofrequency ablation had lower rates of neoplastic progression, according to new research data.

Younger patients with rectal cancer have comparable survival outcomes as middle-aged patients despite more frequently presenting with advanced disease and unfavorable tumor characteristics, according to results of a population-based study conducted in the Netherlands.

Adeno-associated virus type 2, a type of DNA virus, was associated with oncogenic insertional mutagenesis in human hepatocellular carcinoma cells, according to data published in Nature Genetics.

Regen BioPharma, Inc. announced it is currently developing a gene delivery procedure that will enable RGBP-248, a gene silencing nucleic acid, to reach liver tumors and cancerous cells in the body faster and, in turn, treat unresectable liver cancer, according to a press release.

Patients with cancer who had a history of presumed carboplatin- and oxaliplatin-induced hypersensitivity reaction did not appear allergic to the chemotherapy drugs after skin prick tests, according to retrospective study results.

The CMS Advisory Panel on Clinical Diagnostic Laboratory Tests voted unanimously (11-0) to maintain Medicare’s current reimbursement rate of $492.72 for the Cologuard stool DNA screening test for colorectal cancer, Exact Sciences announced.

A microRNA panel that assesses blood plasma levels may distinguish individuals with intraductal papillary mucinous neoplasms in the pancreas from healthy individuals, according to the results of a retrospective analysis.

In a new study, researchers found that people who were obese in early adulthood had an increased risk for developing hepatocellular carcinoma later on, according to published findings.

Surface enhanced Raman spectroscopy analysis of blood plasma was shown to detect colorectal cancer and adenomatous polyps with high accuracy, according to research data.